Oncology: Basic & Translational -> Basic Science (O) 234

234 - GPC3 targeted theranostic platform for hepatocellular carcinoma (ID 40)

Session Name
Basic Oncology & Translational I
Speakers
Authors
Presentation Topic
Oncology: Basic & Translational -> Basic Science (O)
Presentation Number
234

Previous Eposter
232 - Divergent Liver and Brain Levels of 11β-hydroxysteroid Dehydrogenase Type 1 Enzyme in Obesity: Preliminary Results from PET Imaging Studies (ID 39)

Next Eposters
235 - Novel in situ forming depot-based brachytherapy enables intratumoral release of 177Lu and tumor growth delay (ID 37)
236 - Physiologic Colonic Uptake of 18F-FDG on PET/CT Predicts Immunotherapy Response in Patients with Advanced Non-small Cell Lung Cancer (ID 1335)
237 - Prognostic impact of integrative analysis between FDG PET parameters and infiltrating immune cells in lung adenocarcinoma (ID 946)
238 - Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors (ID 949)
240 - Baseline metabolic tumor volume has a strong predictive and prognostic value in non-small cell lung cancer patients treated with immunotherapy (ID 944)
243 - PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab (ID 948)
244 - DMSA renal investigations performed with a 360° whole-body CZT SPECT camera as compared with the conventional method based on planar images from an Anger camera (ID 561)
245 - Practice parameters in diuretic renal scintigraphy across the United States, a need for practice standardization. (ID 555)
246 - Determination of Dose of Lasix in Adult Hydronephrosis and Patients with Chronic Renal Disease (ID 562)
247 - Early postoperative Tc-99m mercaptoacetyltriglycine (MAG3)renal scintigraphy for short term prediction of renal allograft dysfunction (ID 560)